Elucidating the precise pharmacological system of motion (MOA) of naturally occurring compounds can be complicated. Despite the fact that Tarselli et al. (60) produced the initial de novo synthetic pathway to conolidine and showcased that this naturally occurring compound correctly suppresses responses to both chemically induced and inflammation-de